13048_2020_703_MOESM4_ESM.tif (2.7 MB)
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
figure
posted on 2020-08-22, 03:34 authored by Kuo-Chang Wen, Pi-Lin Sung, Alexander T. H. Wu, Ping-Chieh Chou, Jun-Hung Lin, Chi-Ying F. Huang, Sai-Ching J. Yeung, Mong-Hong LeeAdditional file 4: Figure S4. The effects of metformin in normal- or high-glucose culture medium. Western blotting was performed to assess the expression of AMPK, AKT, MTOR, 4E-BP1 and S6 following treatment with metformin, chemotherapy (carboplatin), or both for 48 h in the presence or absence of a high-glucose medium. Beta-actin was included as a loading control.
